Palonosetron

Phase 2Completed
0 watching 0 views this week Active
52
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Multiple Myeloma

Conditions

Multiple Myeloma

Trial Timeline

Mar 1, 2006 → Dec 1, 2007

About Palonosetron

Palonosetron is a phase 2 stage product being developed by Eisai for Multiple Myeloma. The current trial status is completed. This product is registered under clinical trial identifier NCT00306735. Target conditions include Multiple Myeloma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00412425Phase 1/2Completed
NCT00306735Phase 2Completed

Competing Products

20 competing products in Multiple Myeloma

See all competitors